A modified HPLC method improves the simultaneous determination of plasma kynurenine and tryptophan concentrations in patients following maintenance hemodialysis
Authors:
Open Access
- 29 January 2014
- journal article
- Published by Spandidos Publications in Experimental and Therapeutic Medicine
- Vol. 7 (4) , 907-910
Abstract
The ratio between plasma kynurenine (Kyn) and tryptophan (Trp) serves as a marker of indoleamine 2,3‑dioxygenase, a critical immunomodulatory molecule. Simultaneous detection of the two markers may be performed using high‑pressure liquid chromatography (HPLC). However, for uremic patients, the conventional detection method may be affected by a range of accumulated toxins. The current study aimed to establish a method for the simultaneous measurement of Kyn and Trp in patients following maintenance hemodialysis via HPLC‑ultraviolet detection. The procedure involved the use of a SinoChrom ODS‑BP C18 column (4.6x150 mm; inner diameter, 4.5 µm) and a mobile phase of 15 mmol/l sodium acetate acetic acid solution (containing 5% acetonitrile, pH 4.8). The modified method was verified using plasma samples from 10 healthy controls and 91 maintenance hemodialysis patients. The results demonstrated that the modified method was successful in simultaneously detecting the concentrations of Trp and Kyn in the healthy controls and maintenance hemodialysis patients. The method is simple, fast, accurate and suitable for clinical and research purposes in maintenance hemodialysis patients.Keywords
This publication has 13 references indexed in Scilit:
- Plasma Indoleamine 2,3-Dioxygenase Concentration is Increased in Hemodialysis Patients and May Contribute to the Pathogenesis of Coronary Heart DiseaseRenal Failure, 2011
- Highlights of 10 years of immunology in Nature Reviews ImmunologyNature Reviews Immunology, 2011
- Indoleamine 2,3-dioxygenase is a signaling protein in long-term tolerance by dendritic cellsNature Immunology, 2011
- Indoleamine 2,3-dioxygenase is increased in hemodialysis patients and affects immune response to hepatitis B vaccinationVaccine, 2011
- Enhanced degradation of tryptophan in patients on hemodialysisClinical Nephrology, 2010
- Increased indoleamine 2,3-dioxygenase (IDO) activity and elevated serum levels of tryptophan catabolites in patients with chronic kidney disease: a possible link between chronic inflammation and uraemic symptomsNephrology Dialysis Transplantation, 2009
- Non-invasive monitoring of kidney allograft rejection through IDO metabolism evaluationKidney International, 2007
- Ido expression by dendritic cells: tolerance and tryptophan catabolismNature Reviews Immunology, 2004
- Tryptophan Metabolism via the Kynurenine Pathway in Experimental Chronic Renal FailureNephron, 2002
- Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failureKidney International, 1999